Agilon Health, Inc. — Form 8-K Summary
Reporting date: August 10, 2022. This filing reports changes to the company’s board of directors under Item 5.02. It does not provide financial statements or operating results for a reporting period.
Business Context and Corporate Governance
- Michael Smith, age 74, resigned from the board effective August 10, 2022.
- The company stated that Mr. Smith’s resignation was not due to any disagreement with the company’s operations, policies, or practices.
- Jeffrey A. Schwaneke was appointed as a Class I director to fill the vacancy, with a term expiring at the 2025 annual meeting of stockholders.
- Mr. Schwaneke was also appointed to the board’s Audit Committee.
- Mr. Schwaneke previously held senior executive and finance positions at Centene Corporation and is a certified public accountant.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Material Changes Versus the Prior Period
The material change disclosed is a board transition: Mr. Smith resigned and Mr. Schwaneke was appointed as his replacement. No financial or operational comparison with a prior period is provided.
Compensation, Related Parties, and Other Matters
- Mr. Schwaneke will receive compensation under the company’s previously disclosed compensation program for non-officer directors.
- The filing reports no related-party transactions under Item 5.02 or Item 404(a) of Regulation S-K, other than previously disclosed indemnification arrangements with directors.
- No specific compensation amount or equity award value is provided.
Key Investor Verification Items
- Review the company’s subsequent filings for the effect of the new director and Audit Committee composition.
- Verify the terms and amounts of Mr. Schwaneke’s director compensation in the company’s proxy statement or other previously disclosed compensation materials.
- Confirm that future filings do not identify additional reasons for Mr. Smith’s departure or related governance changes.